Basecare cooperated with Haier for assisted reproduction cryopreservation solution

Haier Biomedical CACLP 2022 Booth No.: A7-3211

On July 13, Basecare and Haier formally signed a strategic cooperation agreement in Qingdao, Shandong, China. The two sides will carry out cooperative research and development in the field of assisted reproduction cryopreservation, and jointly provide cryopreservation solutions for the assisted reproduction industry, which is another in-depth industrial cooperation after the cooperation between Basecare and Haichuang master fund capital.

Embryo laboratory, andrology laboratory and low-temperature storage laboratory are important components in the field of assisted reproduction. Among them, low-temperature freezing technology, as an indispensable and important technology in the implementation of assisted reproduction, has been widely used in the field of assisted reproduction, providing guarantee and hope for people in need to realize their reproductive needs and reproductive health. At present, assisted reproduction centers need to invest a lot of storage resources, including storage containers, storage space, management and maintenance, which are increasing year by year. With the increase of infertility and the number of elderly mothers, the demand gap for fertility preservation is still expanding, and the market potential is huge.

Nvwa Life, an innovative enterprise of assisted reproductive technology, received tens of millions of pre-A round of investment

On July 12, Nvwa Life, an innovative company with a new generation of assisted reproductive technology, announced that after completing Angel round and angel round + financing in 2021, it had successfully completed tens of millions of CNY of pre-A financing in April 2022.

Through independent innovation, Nvwa Life has developed a method for AI intelligent screening of high-quality embryos using DNA methylation maps - preimplantation DNA methylation screening technology (PIMS). This technology can simultaneously detect the information of embryo chromosome copy number variation and DNA methylation level, and intelligently screen the quality of embryo development in combination with AI intelligent algorithm, which has brought a new technical theory and solution to assisted reproductive medicine. It has greatly solved the technical challenges faced by assisted reproductive medicine and provided a guarantee for improving fertility.

Third generation sequencing technology of Berry Genomics helps the application of assisted reproduction

On July 11, director Wang Xiaohong, the reproductive medicine center of Tangdu Hospital of the Air Force Military Medical University, innovatively applied Berry Genomics third-generation sequencing embryo preimplantation genetic testing technology (PGT-SR) to the assisted reproduction population in the hospital. Recently, the baby who was successfully born has been in good health for 100 days, and all growth and development indicators are normal.

According to Director Wang, the reproductive medicine center of Obstetrics and Gynecology of Tangdu Hospital has been constantly optimizing and updating the screening technology of balanced translocation chromosome carriers before embryo implantation. This time, the third-generation sequencing technology is applied to the screening of balanced translocation chromosome carriers before embryo implantation, which can detect balanced translocation breakpoints in the whole genome more comprehensively and accurately than other embryo balanced translocation detection technologies. There is no need to compare family members or unbalanced abnormal embryos for analysis.